TW326045B - N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. - Google Patents
N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation.Info
- Publication number
- TW326045B TW326045B TW083101092A TW83101092A TW326045B TW 326045 B TW326045 B TW 326045B TW 083101092 A TW083101092 A TW 083101092A TW 83101092 A TW83101092 A TW 83101092A TW 326045 B TW326045 B TW 326045B
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- compound
- formula
- pharmaceutically acceptable
- inhibition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939302636A GB9302636D0 (en) | 1993-02-10 | 1993-02-10 | Compounds |
GB939325712A GB9325712D0 (en) | 1993-12-16 | 1993-12-16 | Compounds |
PCT/GB1994/000237 WO1994018216A1 (en) | 1993-02-10 | 1994-02-08 | N-alkyl-2-substituted atp analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
TW326045B true TW326045B (en) | 1998-02-01 |
Family
ID=26302434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW083101092A TW326045B (en) | 1993-02-10 | 1994-02-08 | N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. |
Country Status (26)
Country | Link |
---|---|
US (2) | US5721219A (zh) |
EP (1) | EP0683789B1 (zh) |
JP (1) | JP3083156B2 (zh) |
KR (1) | KR100315612B1 (zh) |
CN (1) | CN1042430C (zh) |
AT (1) | ATE159950T1 (zh) |
AU (1) | AU679721B2 (zh) |
CA (1) | CA2155673C (zh) |
CZ (1) | CZ286050B6 (zh) |
DE (1) | DE69406649T2 (zh) |
DK (1) | DK0683789T3 (zh) |
ES (1) | ES2108425T3 (zh) |
FI (1) | FI110687B (zh) |
GR (1) | GR3025995T3 (zh) |
HK (1) | HK1002936A1 (zh) |
HU (1) | HU221501B (zh) |
IL (1) | IL108602A (zh) |
NO (1) | NO305209B1 (zh) |
NZ (1) | NZ261159A (zh) |
PL (1) | PL175623B1 (zh) |
RU (1) | RU2136693C1 (zh) |
SG (1) | SG47943A1 (zh) |
SK (1) | SK281309B6 (zh) |
TW (1) | TW326045B (zh) |
UA (1) | UA54366C2 (zh) |
WO (1) | WO1994018216A1 (zh) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW326045B (en) * | 1993-02-10 | 1998-02-01 | Astra Pharma Prod | N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. |
WO1998018430A2 (en) * | 1996-10-30 | 1998-05-07 | The University Of North Carolina At Chapel Hill | P2y receptor antagonists |
US6686462B2 (en) * | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
SE9702680D0 (sv) * | 1997-07-11 | 1997-07-11 | Astra Pharma Prod | New formulation |
AU2003257524B2 (en) * | 1997-07-11 | 2006-04-06 | Astrazeneca Ab | New formulation |
FI104901B (fi) * | 1997-10-20 | 2000-04-28 | Leiras Oy | Uudet metyleenibisfosfonihappojohdannaiset |
US8586781B2 (en) * | 1998-04-02 | 2013-11-19 | Mbc Pharma, Inc. | Bone targeted therapeutics and methods of making and using the same |
US6750340B2 (en) * | 1998-04-02 | 2004-06-15 | Mbc Research, Inc. | Bisphosphonate conjugates and methods of making and using the same |
US7598246B2 (en) * | 1998-04-02 | 2009-10-06 | Mbc Pharma, Inc. | Bisphosphonate conjugates and methods of making and using the same |
TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
US7205404B1 (en) * | 1999-03-05 | 2007-04-17 | Metabasis Therapeutics, Inc. | Phosphorus-containing prodrugs |
US6303774B1 (en) * | 1999-08-20 | 2001-10-16 | Sri International | Nucleoside pyrophosphate and triphosphate analogs and related compounds |
SE9903345D0 (sv) | 1999-09-17 | 1999-09-17 | Astra Pharma Prod | Novel process |
SE9904377D0 (sv) * | 1999-12-01 | 1999-12-01 | Astra Pharma Prod | Pharmaceutical combinations |
US7452870B2 (en) | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US6867199B2 (en) | 2000-08-21 | 2005-03-15 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapeutic use |
US7115585B2 (en) | 2000-08-21 | 2006-10-03 | Inspire Pharmaceuticals, Inc. | Compositions for treating epithelial and retinal tissue diseases |
US6897201B2 (en) | 2000-08-21 | 2005-05-24 | Inspire Pharmaceuticals, Inc. | Compositions and methods for the treatment of glaucoma or ocular hypertension |
US7018985B1 (en) * | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
AR039558A1 (es) * | 2000-08-21 | 2005-02-23 | Inspire Pharmaceuticals Inc | Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular |
US7132408B2 (en) | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7435724B2 (en) | 2002-02-27 | 2008-10-14 | Inspire Pharmaceutical, Inc. | Degradation-resistant mononucleoside phosphate compounds |
EP1485395A4 (en) * | 2002-02-28 | 2011-04-13 | Biota Scient Management | NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF |
RU2005104432A (ru) * | 2002-07-18 | 2005-08-10 | Санкио Компани, Лимитед (Jp) | Лекарственная композиция для лечения артериосклероза |
US20050192245A1 (en) * | 2002-07-18 | 2005-09-01 | Sankyo Company, Limited | Medicinal composition for treating arteriosclerosis |
AU2003284594B2 (en) | 2002-11-21 | 2009-01-15 | Kowa Co., Ltd | Peritoneal dialysis method |
US8293890B2 (en) * | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
EP1604669A1 (en) * | 2004-06-10 | 2005-12-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of ATP analogues for treatment of cardiovascular diseases |
WO2009140092A1 (en) | 2008-05-13 | 2009-11-19 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US9427448B2 (en) | 2009-11-11 | 2016-08-30 | The Medicines Company | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
US20120141468A1 (en) | 2008-05-13 | 2012-06-07 | Lisa Ruderman Chen | Maintenance of platelet inhibition during antiplatelet therapy |
US8759316B2 (en) * | 2008-05-13 | 2014-06-24 | The Medicines Company | Maintenance of platelet inhibition during antiplatelet therapy |
US20130303477A1 (en) * | 2008-05-13 | 2013-11-14 | The Medicines Company | Maintenance of Platelet Inhibition During Antiplatelet Therapy |
US10376532B2 (en) | 2009-11-11 | 2019-08-13 | Chiesi Farmaceutici, S.P.A. | Methods of treating, reducing the incidence of, and/or preventing ischemic events |
AU2010319612B2 (en) * | 2009-11-11 | 2016-01-14 | Chiesi Farmaceutici S.P.A. | Methods of treating or preventing stent thrombosis |
EP2669292B1 (en) * | 2011-01-26 | 2017-03-29 | Beijing KBD Pharmaceuticals Co., Ltd. | Ribofuranosyl purine compounds for treating diseases associated with platelet aggregation |
BR112013020377B1 (pt) * | 2011-02-09 | 2022-06-07 | Chiesi Farmaceutici S.P.A. | Usos de um antagonista do receptor p2y12 reversível na fabricação de um medicamento útil para o tratamento da hipertensão pulmonar |
CA2843885C (en) | 2011-08-01 | 2020-03-10 | Mbc Pharma, Inc. | Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates |
CN115120606A (zh) | 2013-03-09 | 2022-09-30 | 奇斯药制品公司 | 治疗局部缺血事件、减少局部缺血事件的发生和/或预防局部缺血事件的方法 |
CN104447928A (zh) * | 2013-09-13 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 坎格雷洛二水化合物 |
CN104447927A (zh) * | 2013-09-13 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 坎格雷洛一水合物晶体及其制备方法 |
CN103772461A (zh) * | 2014-01-06 | 2014-05-07 | 南京正科制药有限公司 | 一种坎格雷洛晶型ⅰ |
WO2015123352A1 (en) | 2014-02-13 | 2015-08-20 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
CN106687118A (zh) | 2014-07-02 | 2017-05-17 | 配体药物公司 | 前药化合物及其用途 |
CN105273025B (zh) * | 2014-07-22 | 2019-07-26 | 上海医药工业研究院 | 一种制备坎格雷洛的中间体及其制备方法和应用 |
PE20221170A1 (es) | 2015-01-14 | 2022-07-25 | Chiesi Farm Spa | Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para la preparacion y uso de los mismos |
CN105061431B (zh) * | 2015-07-28 | 2017-03-29 | 山东百诺医药股份有限公司 | 6‑n‑(2‑(甲硫基)乙基)‑2‑((3,3,3‑三氟丙基)硫代)‑9h‑嘌呤及其制备方法和应用 |
CN109232694A (zh) * | 2015-11-06 | 2019-01-18 | 江苏恒瑞医药股份有限公司 | 制备坎格雷洛中间体的方法 |
CN107973798B (zh) * | 2016-10-25 | 2020-04-24 | 上海医药工业研究院 | 2-[(3,3,3-三氟丙基)硫代]-6-氨基-9h-嘌呤及制法 |
CN107973832B (zh) * | 2016-10-25 | 2021-11-12 | 上海医药工业研究院 | 6-n-[2-(甲硫基)乙基]-2-[(3,3,3-三氟丙基)硫代]腺苷的制法 |
CN106674322B (zh) * | 2016-12-07 | 2019-04-16 | 上海博志研新药物技术有限公司 | 一种坎格雷洛中间体的纯化方法 |
WO2018185715A1 (en) * | 2017-04-06 | 2018-10-11 | Msn Laboratories Private Limited, R&D Center | Improved process for the preparation of n6-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-5'-adenylic acid, monoanhydride with (dichloromethylene) bisphosphonic acid and its pharmaceutically acceptable salts |
WO2018234565A1 (en) | 2017-06-23 | 2018-12-27 | Chiesi Farmaceutici S.P.A. | METHOD FOR PREVENTING SHUNT THROMBOSIS FROM THE SYSTEMIC-PULMONARY ARTERY |
ES2905104T3 (es) * | 2017-11-10 | 2022-04-07 | Olon Spa | Método eficiente para la preparación de Cangrelor |
CN109912674A (zh) * | 2017-12-12 | 2019-06-21 | 亚宝药业集团股份有限公司 | 一种坎格雷洛四钠盐的制备方法 |
CN111788196A (zh) | 2018-01-09 | 2020-10-16 | 配体药物公司 | 缩醛化合物及其治疗用途 |
US20190241606A1 (en) * | 2018-02-05 | 2019-08-08 | Scinopharm Taiwan, Ltd. | Process for preparation of cangrelor tetrasodium and intermediate therefor |
CN108033983B (zh) * | 2018-02-09 | 2021-06-08 | 盐城锦明药业有限公司 | 一种2‐(3,3,3‐三氟丙基)硫代腺苷的合成方法 |
EP4289435A1 (en) | 2022-06-07 | 2023-12-13 | Université de Liège | N-alkyl-2-substituted atp analogues for use as antibacterial agent |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049550A (en) * | 1987-11-05 | 1991-09-17 | Worcester Foundation For Experimental Biology | Diadenosine 5', 5'"-p1, p4,-tetraphosphate analogs as antithrombotic agents |
WO1990011080A1 (fr) * | 1989-03-24 | 1990-10-04 | Daiichi Pharmaceutical Co., Ltd. | Medicament ameliorant les fonctions cerebrales |
GB9107236D0 (en) | 1991-04-06 | 1991-05-22 | Fisons Plc | Compounds |
ATE127808T1 (de) * | 1991-04-06 | 1995-09-15 | Fisons Plc | Atp-analogen. |
TW326045B (en) * | 1993-02-10 | 1998-02-01 | Astra Pharma Prod | N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. |
-
1994
- 1994-02-08 TW TW083101092A patent/TW326045B/zh not_active IP Right Cessation
- 1994-02-08 PL PL94310160A patent/PL175623B1/pl unknown
- 1994-02-08 KR KR1019950703322A patent/KR100315612B1/ko not_active IP Right Cessation
- 1994-02-08 EP EP94905810A patent/EP0683789B1/en not_active Expired - Lifetime
- 1994-02-08 WO PCT/GB1994/000237 patent/WO1994018216A1/en active IP Right Grant
- 1994-02-08 SG SG1996005584A patent/SG47943A1/en unknown
- 1994-02-08 AT AT94905810T patent/ATE159950T1/de active
- 1994-02-08 CN CN94191559A patent/CN1042430C/zh not_active Expired - Lifetime
- 1994-02-08 CA CA002155673A patent/CA2155673C/en not_active Expired - Lifetime
- 1994-02-08 NZ NZ261159A patent/NZ261159A/en not_active IP Right Cessation
- 1994-02-08 AU AU59770/94A patent/AU679721B2/en not_active Expired
- 1994-02-08 HU HU9502348A patent/HU221501B/hu unknown
- 1994-02-08 RU RU95118285/04A patent/RU2136693C1/ru active
- 1994-02-08 ES ES94905810T patent/ES2108425T3/es not_active Expired - Lifetime
- 1994-02-08 DK DK94905810.1T patent/DK0683789T3/da active
- 1994-02-08 CZ CZ952032A patent/CZ286050B6/cs not_active IP Right Cessation
- 1994-02-08 JP JP06517805A patent/JP3083156B2/ja not_active Expired - Lifetime
- 1994-02-08 SK SK994-95A patent/SK281309B6/sk not_active IP Right Cessation
- 1994-02-08 DE DE69406649T patent/DE69406649T2/de not_active Expired - Lifetime
- 1994-02-09 IL IL10860294A patent/IL108602A/en not_active IP Right Cessation
- 1994-08-02 UA UA95094059A patent/UA54366C2/uk unknown
-
1995
- 1995-08-09 NO NO953126A patent/NO305209B1/no not_active IP Right Cessation
- 1995-08-09 US US08/512,979 patent/US5721219A/en not_active Expired - Lifetime
- 1995-08-10 FI FI953794A patent/FI110687B/fi not_active IP Right Cessation
-
1997
- 1997-08-28 US US08/918,670 patent/US5955447A/en not_active Expired - Lifetime
-
1998
- 1998-01-26 GR GR980400166T patent/GR3025995T3/el unknown
- 1998-03-10 HK HK98102001A patent/HK1002936A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW326045B (en) | N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. | |
HUP9802822A2 (hu) | Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények | |
DK0574545T3 (da) | Phenylamidinderivater som blodpladeaggregationsinhibitorer | |
DK0665844T3 (da) | Substituerede benzylaminoquinuclidinforbindelser som antagonister af substans P | |
TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
ZA926049B (en) | New 3,5 di-tert.-Butyl-4-hydroxyphenyl derivatives processes for the preparation thereof and pharmaceutical compositions containg them. | |
EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
TW268948B (zh) | ||
CO5080791A1 (es) | Derivados de la piperidina que tienen efectos sobre sistemas con serotonina | |
MY118004A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
ES8504653A1 (es) | Un procedimiento para preparar nuevos derivados de eteno | |
ES8707970A1 (es) | Procedimiento para la obtencion de nuevos derivados de la pristinamicina ii b | |
TW427993B (en) | New cephem compounds | |
MX9305932A (es) | Derivados de piperidina, su preparacion y su aplicacion en terapeutica. | |
NZ205739A (en) | Heterocyclic ethane derivatives and fungicidal compositions | |
ES8707951A1 (es) | Derivados de tetrazol | |
IL103417A0 (en) | Bis(phenyl)ethane derivatives,their preparation and pharmaceutical compositions containing them | |
HUP0303828A2 (hu) | CDC25 foszfatáz inhibitorok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására | |
ATE94050T1 (de) | Mittel zur verhinderung von zahnbelagbildung. | |
SI1572198T1 (sl) | Nove farmacevtske spojine z alfa2 receptorsko aktivnostjo | |
SE7502243L (zh) | ||
TH14595EX (th) | เกลือเซฟาโลสพอริน และกรรมวิธีสำหรับเตรียมสารนั้น |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |